Analyst is bullish on Vertex Pharmaceuticals, citing FDA approval for JOURNAVX and strong earnings growth potential in 2025.
Shares of Teleflex Inc. TFX slid 1.42% to $180.24 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index SPX falling 0.50% to 6,040.53 and Dow ...
French luxury conglomerate LVMH saw its stock slide by more than 6% following the Tuesday evening reveal of its 2024 annual ...
Check the time stamp on this data. Updated AI-Generated Signals for Dimensional Global Ex Us Core Fixed Income Etf (DFGX) ...
Liberty Media Corp. Series C Liberty Formula One 0.03% $30.17B Liberty Media Corp. Series A Liberty Formula One-0.07% $30.17B Liberty Broadband Corp. Cl A 3.89% $10.68B Liberty Broadband Corp. Cl ...
The Zacks Diversified Operations industry has been grappling with persistent weakness in the manufacturing sector. Industry ...